Related Experiment Video
Updated: Mar 22, 2026
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Dendritic Cell Vaccines
Rachel Lubong Sabado1, Marcia Meseck2, Nina Bhardwaj2
1Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. rachel.sabado@mssm.edu.
Abstract:
Exploitation of the patient's own immune system to induce antitumor immune responses using dendritic cell (DC) immunotherapy has been established in early clinical trials as a safe and promising therapeutic approach for cancer. However, their limited success in larger clinical trials highlights the need to optimize DC vaccine preparations. This chapter describes the methodologies utilized for the preparation of the DC vaccine most commonly used in clinical trials. Optional variations at different stages in DC vaccine preparation, based on the nature of antigen, delivery of antigen, maturation stimuli, and mode of administration for DC vaccines, are also presented for consideration as these are often dependent on the disease setting, desired immune response, and/or resources available.
Insights
Dendritic cell (DC) immunotherapy shows promise for cancer treatment by harnessing the immune system. Optimizing DC vaccine preparation methods is crucial for improving clinical success in cancer patients.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Dendritic cell (DC) immunotherapy utilizes the patient's immune system to fight cancer.
- Early trials show DC immunotherapy is safe and promising for cancer treatment.
Purpose of the Study:
- To describe common methods for preparing DC vaccines used in clinical trials.
- To present variations in DC vaccine preparation for different cancer types and treatment goals.
Main Methods:
- Detailed methodologies for DC vaccine preparation are outlined.
- Considerations for antigen type, delivery, maturation stimuli, and administration are discussed.
Main Results:
- The chapter focuses on established DC vaccine preparation techniques.
- Variations are presented based on disease, desired immune response, and available resources.
Conclusions:
- Optimizing DC vaccine preparation is essential for enhancing clinical efficacy.
- Flexible approaches to DC vaccine design can be tailored to specific patient needs and settings.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:51Vaccinations
01:21Vaccines
01:22Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...